Frontlight ResearchEarly access
Active, not recruitingNo phase
Harmony TPV Post-Approval Study
Key facts
- Who runs it
- Medtronic Cardiovascular
- Where
- Ann Arbor, Aurora, Birmingham, Boston, Charleston, Charlotte, Charlottesville, Cincinnati, Cleveland, Dallas, Durham, Los Angeles, New York, Oak Lawn, Omaha, Pittsburgh, St Louis, and Tampa, United StatesSee the 19 sitesAlso in 1 other country, 1 site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 174 people enrolled
- Started
- 25 Oct 2021
- Expected to end
- Mar 2035
- Type of study
- Interventional
- Treatments tested
- Harmony TPV System
- Record updated
- 1 October 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Patient eligible to receive the Harmony TPV, meeting the indications for use criteria per current geography-specific device labeling at time of study enrollment
- Patient (or patient's legally authorized representative) is willing to consent to participate in the study
Who cannot take part
- Planned concomitant branch pulmonary artery stenting at time of implant
- Subject is pregnant at time of implant procedure
- Patients with previously treated with an RV-PA conduit or previously implanted bioprosthesis
- A major or progressive non-cardiac disease (e.g. liver failure, renal failure, cancer) that results in a life expectancy of less than one year
- Planned implantation of the Harmony TPV in the left heart
- Pre-existing prosthetic heart valve or prosthetic ring in any position
- Obstruction of the central veins
- Echocardiographic evidence of intracardiac mass, thrombus, or vegetation
Where in United States
Also in 1 other country, 1 site
- University of Michigan Health SystemAnn Arbor, United States
- Children's Hospital ColoradoAurora, United States
- University of Alabama At Birmingham HospitalBirmingham, United States
- Boston Children's HospitalBoston, United States
- Medical University of South CarolinaCharleston, United States
- Atrium Health/Levine Children's HospitalCharlotte, United States
- University of VirginiaCharlottesville, United States
- Cincinnati Children's Hospital Medical CenterCincinnati, United States
- Cleveland ClinicCleveland, United States
- Medical City Children's HospitalDallas, United States
- Duke University Medical CenterDurham, United States
- Cedars-Sinai Medical CenterLos Angeles, United States
- Children's Hospital New York-PresbyterianNew York, United States
- The Mount Sinai HospitalNew York, United States
- Advocate Christ Medical CenterOak Lawn, United States
- Children'S Hospital & Medical CenterOmaha, United States
- UPMC Children's Hospital of PittsburghPittsburgh, United States
- Saint Louis Children's HospitalSt Louis, United States
- St. Joseph Children's HospitalTampa, United States
About the trial
What the trial wants to find out
The purpose of this study is to characterize the functionality of transcatheter implantation of the Medtronic Harmony Transcatheter Pulmonary Valve (TPV) achieved by real-world implanters.
The group in the trial
- Harmony TPV SystemOther group
Intervention Device: Harmony Transcatheter Pulmonary Valves and Delivery System
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Harmony TPV Post-Approval Study (Harmony PAS2)
- Publications
- 1-Year Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Clinical Trial Participants.JACC. Cardiovascular interventions, 2023
- Record updated
- 1 October 2026